Professor Gabor Mikala graduated with honors in 1991 at Semmelweis University, Budapest as a medical doctor. From 1991 to 1997 worked at the University of Cincinnati, Institute of Molecular Pharmacology and Biophysics, as a Program of Excellence Fellow. Upon returning to Hungary, he worked at Imre Haynal University as a clinical resident, received board certification in internal medicine and hematology. Received a PhD degree in 2000 from Semmelweis University, Program of Molecular Physiology. Has had a joint appointment as professor of anatomy, physiology and cell biology at Semmelweis University School of Health Sciences. Presently Head of Division for Lymphoma and Myeloma Care at South Pest Central Hospital, National Institute for Hematology and Infectious Diseases. His major interest is in plasma cell dyscrasias, authored more than 150 publications with more than 4500 citations. He is a governing board member of the Hungarian Society of Hematology, member of the International Myeloma Working Group, International Myeloma Society, serves as an editorial board member of several scientific journals. Co-author of the Hungarian myeloma treatment guidelines.
